Iterum Therapeutics Stock Price - ITRM

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 3.00 ▲ 0.06 (2.04%)
Company Name Stock Ticker Symbol Market Type
Iterum Therapeutics PLC ITRM NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.36 -10.91% 2.94 3.5138 2.85 3.33 3.30 20:00:00
Bid Price Ask Price Spread Spread % News
2.50 3.09 0.59 19.09% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,110 560,608 $ 3.03 $ 1,700,749 566,106 1.68 - 9.3007
Last Trade Time Type Quantity Stock Price Currency
17:55:02 10 $ 3.00 USD

Iterum Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 43.71M 14.87M $ -77.06M -6.31 - 14.36M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 3.40%

more financials information »

Iterum Therapeutics News

Loading Messages....

Latest ITRM Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ITRM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.004.752.853.49182,496-1.06-26.5%
1 Month2.546.472.404.71747,2550.4015.75%
3 Months3.587.191.684.33326,814-0.64-17.88%
6 Months6.47947.64991.684.38153,688-3.54-54.63%
1 Year5.979.30071.684.5282,771-3.03-50.75%
3 Years12.7013.001.685.7163,531-9.76-76.85%
5 Years12.7013.001.685.7163,531-9.76-76.85%

Iterum Therapeutics Description

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents.

Your Recent History
Iterum The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.